Home
Conditions
Lung Diseases, Interstitial

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

60 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Recruiting

European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank

NCT02852928

Conditions: Child, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eosinophilia, +18 more
Locations: Medizinische Hochschule Hannover Hanover, Lower Saxony, Germany

Hacettepe University, Medical Faculty Ankara, Sihhiye, Turkey (Türkiye)

University of Edinburgh Edinburgh, United Kingdom

View Trial Details

Not yet recruiting

Family-centred Pulmonary Rehabilitation to Empower Carers

NCT07791147

Conditions: Asthma, Bronchial Diseases, Bronchiectasis, +18 more
Locations: Unidade Local de Saúde Região de Aveiro Aveiro, Aveiro District, Portugal

Unidade Local de Saúde Entre o Douro e Vouga Santa Maria da Feira, Aveiro District, Portugal

Unidade Local de Saúde Baixo Mondego Figueira da Foz Municipality, Coimbra District, Portugal

Unidade Local de Saúde Santa Maria Lisbon, Lisbon District, Portugal

View Trial Details

Active, not recruiting

Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD

NCT05867914

Conditions: Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations: TGH/USF Center for Advanced Lung Disease and Lung Transplant Tampa, Florida, United States

University of Cincinnati Cincinnati, Ohio, United States

Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

NCT04325217

Conditions: Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations: Nippon Boehringer Ingelheim Co., Ltd. Tokyo, Japan

View Trial Details

Completed

NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

NCT05722340

Conditions: Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations: Département d'Anesthésie et Réanimation Cardiothoracique - CHU Arnaud de Villeneuve Montpellier, France

View Trial Details

Completed

A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease

NCT05492994

Conditions: Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations: Medizinische Hochschule Hannover Hanover, Germany

View Trial Details

Completed

Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise

NCT03718780

Conditions: Chronic Disease, Chronic Heart Failure, Disease Attributes, +11 more
Locations: Service de pneumologie Béthune, France

Service de pneumologie CHMS Chambéry, France

Service de réanimation médicale - CHMS Chambéry, France

Service de Pneumologie CHU Grenoble La Tronche, France

View Trial Details

Completed

BPF Genetics of ILD Study

NCT03747627

Conditions: Alveolitis, Extrinsic Allergic, Bird Fancier's Lung, Disease, +14 more
Locations: Royal Pigeon Racing Association Meeting Blackpool, United Kingdom

Scottish Homing Union Lanark, United Kingdom

View Trial Details

Completed

A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)

NCT05285982

Conditions: Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Weill Cornell Medicine-New York-60569 New York, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View all 28 locations

View Trial Details

Completed

Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan

NCT04559581

Conditions: Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations: Nippon Boehringer Ingelheim Co., Ltd. Tokyo, Japan

View Trial Details

Lung Diseases, Interstitial

Lung Diseases, Interstitial trial results

Related conditions